A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Patients with Diabetic Macular Edema (YOSEMITE)
Amy Pikalek
ARIS
Age-Related Macular Degeneration Ryan Initiative Study (ARIS)
DOVS Hosts 2018 Multiphasic Phaco Course
The Department of Ophthalmology and Visual Sciences hosted the annual 2018 Multiphasic Phaco Course on August 17-18 at the Health Sciences Learning Center. The Phaco Course is a two-day event for our residents. Residents and …
UW Pioneer Leaves Legacy of Sight
The world has lost one of the pillars of modern vision research and ophthalmic clinical care; Dr. Matthew Dinsdale (Dinny) Davis passed away Monday, March 5, 2018, surrounded by loved ones. He leaves a legacy …
AMBLYOPIA TREATMENT STUDY (ATS20)
Binocular Dig Rush Game Treatment for Amblyopia
AREDS2
Age-Related Eye Disease Study 2 (AREDS2) 10-Year Follow-On Study
Zoster Eye Disease Study (ZEDS)
A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Suppressive Valacyclovir for One Year in Immunocompetent Study Participants with an Episode of Dendriform Epithelial Keratitis, Stromal Keratitis, Endothelial Keratitis, and/or Iritis Due to Herpes Zoster Ophthalmicus (HZO) in the Year Prior to Enrollment (ZEDS)
CHROMA
A Phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lampalizumab administered intravitreally to patients with geographic atrophy secondary to age-related macular degeneration.
INTERMITTENT EXOTROPIA STUDY (IXT1)
A Randomized Trial of Bilateral Lateral Rectus Recession versus Unilateral Lateral Rectus Recession with Medial Rectus Resection for Intermittent Exotropia